Combination of niraparib and bevacizumab versus niraparib alone as treatment of recurrent platinum-sensitive ovarian cancer: A randomized controlled chemotherapy-free study-NSGO-AVANOVA2/ENGOT-OV24.

Mansoor Raza Mirza, Elisabeth Avall-Lundqvist, Michael J. Birrer, Rene dePont Christensen, Gitte-Bettina Nyvang, Susanne Malander, Maarit Anttila, Theresa Louise Werner, Bente Lund, Gabriel Lindahl, Sakari Hietanen, Ulla Peen, Maria Dimoula, Henrik Roed, Anja Or Knudsen, Louisa Boufercha, Synnove Staff, Anders Krog Vistisen, Line Bjorge, Johanna Unelma Maenpaa

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Original languageEnglish
Article number5505
JournalJournal of Clinical Oncology
Issue number15, Suppl.
Publication statusPublished - 20 May 2019
EventAnnual Meeting of the American Society of Clinical Oncology (ASCO) - Chicago, United States
Duration: 31 May 20194 Jun 2019


ConferenceAnnual Meeting of the American Society of Clinical Oncology (ASCO)
Country/TerritoryUnited States

Cite this